drugset / Trial / NCT00004230
Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation
RandomizedSupportive care
Summary
RATIONALE: Captopril may protect the lungs from the side effects of bone marrow or stem cell transplantation. PURPOSE: Randomized phase III trial to determine the effectiveness of captopril to lessen the side effects in patients who are undergoing bone marrow or stem cell transplantation following chemotherapy and radiation therapy.
Timeline
- Start
- 1999-10
- Primary completion
- 2002-03
- Completion
- 2002-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Captopril | Small molecule | — | Oral |
| Background | Cyclophosphamide | Other / unclassified | — | — |